10-Q
Quarterly Report
60 DEGREES PHARMACEUTICALS, INC.
SXTPW
NASDAQ
CIK: 1946563
File #: 001-41719
Balance Sheet
44 line items · 2 periods
XBRL
| Item | Jun 30, 2026 | Dec 31, 2025 |
|---|---|---|
ASSETS: | ||
Current Assets: | ||
Cash and Cash Equivalents | 1,022,606 | 1,510,065 |
Accounts Receivable | 567,040 | 509,644 |
Prepaid and Other Assets | 1,263,706 | 978,131 |
Short-Term Investments | — | 1,240,721 |
Inventory (Note 3) | 877,945 | 656,924 |
Total Current Assets | 3,731,297 | 4,895,485 |
Property and Equipment, net (Note 4) | 242,714 | 246,365 |
Other Assets: | ||
Intangible Assets, net (Note 5) | 308,683 | 224,361 |
Total Other Assets | 308,683 | 224,361 |
Total Assets | 4,282,694 | 5,366,211 |
LIABILITIES AND SHAREHOLDERS' EQUITY: | ||
Current Liabilities: | ||
Accounts Payable and Accrued Expenses (Note 6) | 1,218,119 | 1,459,279 |
SBA EIDL (including accrued interest) (Note 8) | 2,003 | 8,772 |
Derivative Liabilities (Note 9) | 384,973 | 374,741 |
Contingent Milestone Payment - Fair Value, Inputs, Level 3 - Fair Value, Recurring | 384,973 | 374,741 |
Fair Value, Inputs, Level 3 | 384,973 | 374,741 |
Derivative Liabilities | 384,973 | 374,741 |
Fair Value, Inputs, Level 3 - Derivative Liabilities | 384,973 | 374,741 |
Total Current Liabilities | 1,605,095 | 1,842,792 |
Long-Term Liabilities: | ||
SBA EIDL (including accrued interest) (Note 8) | 149,176 | 144,003 |
Total Long-Term Liabilities | 149,176 | 144,003 |
Total Liabilities | 1,754,271 | 1,986,795 |
SHAREHOLDERS' EQUITY: | ||
Series A Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; 76,480 and 76,480 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (Note 7) | 9,567,439 | 9,567,439 |
Common Stock, $0.0001 par value, 150,000,000 shares authorized; 2,659,288 and 1,163,142 shares issued and outstanding as of Jun 30, 2026 and Dec 31, 2025, respectively (Note 7) | 264 | 116 |
Additional Paid-in Capital | 45,142,245 | 41,646,139 |
Accumulated Other Comprehensive Income | 151,092 | 142,598 |
Accumulated Deficit | (52,246,855) | (47,893,115) |
60P Shareholders’ Equity: | 2,614,185 | 3,463,177 |
Noncontrolling Interest | (85,762) | (83,761) |
Total Shareholders' Equity | 2,528,423 | 3,379,416 |
Common Stock, par value $0.0001 per share | 264 | 116 |
Series A - Preferred Stock | 9,567,439 | 9,567,439 |
Additional Paid-In Capital | 45,142,245 | 41,646,139 |
Accumulated Deficit | (52,246,855) | (47,893,115) |
Accumulated Other Comprehensive Income (Loss) | 151,092 | 142,598 |
Total Shareholders’ Equity (Deficit) Attributable to 60P | 2,614,185 | 3,463,177 |
Noncontrolling Interest on Shareholders | (85,762) | (83,761) |
Total Liabilities and Shareholders' Equity | 4,282,694 | 5,366,211 |